Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William F Goins

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Current Issues in Molecular Biology|September 17, 2020
Oncolytic HSV Vectors and Anti-Tumor ImmunityJoseph C Glorioso, Justus B Cohen, William F Goins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2018
Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental GlioblastomaHiroshi Nakashima, Tran Nguyen, Kazue Kasai, et al.
Molecular Therapy Oncolytics|January 1, 2020
GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal SurvivalPaola Sette, Nduka Amankulor, Aofei Li, et al.
Molecular Therapy Oncolytics|December 4, 2018
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune MicroenvironmentNicholas L Denton, Chun-Yu Chen, Brian Hutzen, et al.
Scientific Reports|March 22, 2020
Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responsesQuazim A Alayo, Hirotaka Ito, Carmela Passaro, et al.
Nature Reviews. Neurology|April 24, 2013
Progress in gene therapy for neurological disordersMichele Simonato, Jean Bennett, Nicholas M Boulis, et al.
Molecular Therapy. Oncology|December 15, 2025
An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastomaJoseph W Jackson, Bonnie L Hall, Chaim Sneiderman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSVLucia Mazzacurati, Marco Marzulli, Bonnie Reinhart, et al.
Molecular Pain|May 13, 2015
Current gene therapy using viral vectors for chronic painJean-Marc G Guedon, Shaogen Wu, Xuexing Zheng, et al.
The Journal of Clinical Investigation|November 3, 2015
Histone deacetylase 6 inhibition enhances oncolytic viral replication in gliomaHiroshi Nakashima, Johanna K Kaufmann, Pin-Yi Wang, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Current Issues in Molecular Biology|September 17, 2020
Oncolytic HSV Vectors and Anti-Tumor ImmunityJoseph C Glorioso, Justus B Cohen, William F Goins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2018
Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental GlioblastomaHiroshi Nakashima, Tran Nguyen, Kazue Kasai, et al.
Molecular Therapy Oncolytics|January 1, 2020
GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal SurvivalPaola Sette, Nduka Amankulor, Aofei Li, et al.
Molecular Therapy Oncolytics|December 4, 2018
Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune MicroenvironmentNicholas L Denton, Chun-Yu Chen, Brian Hutzen, et al.
Scientific Reports|March 22, 2020
Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responsesQuazim A Alayo, Hirotaka Ito, Carmela Passaro, et al.
Nature Reviews. Neurology|April 24, 2013
Progress in gene therapy for neurological disordersMichele Simonato, Jean Bennett, Nicholas M Boulis, et al.
Molecular Therapy. Oncology|December 15, 2025
An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastomaJoseph W Jackson, Bonnie L Hall, Chaim Sneiderman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2014
Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSVLucia Mazzacurati, Marco Marzulli, Bonnie Reinhart, et al.
Molecular Pain|May 13, 2015
Current gene therapy using viral vectors for chronic painJean-Marc G Guedon, Shaogen Wu, Xuexing Zheng, et al.
The Journal of Clinical Investigation|November 3, 2015
Histone deacetylase 6 inhibition enhances oncolytic viral replication in gliomaHiroshi Nakashima, Johanna K Kaufmann, Pin-Yi Wang, et al.
Pageof 8